Novartis AG is 186.1x more valuable than ANAPTYSBIO, INC by market capitalization ($293.70 B vs $1.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANAB | NVS |
|---|---|---|
| Market cap | $1.58 B | $293.70 B |
| US-listed rank | #2296 | #46 |
| Revenue (latest FY) | $234.60M | - |
| Net income (latest FY) | -$13.23M | - |
| Net margin | -5.6% | - |
| SEC filings | 681 | 947 |
Novartis AG is 186.1x more valuable than ANAPTYSBIO, INC by market capitalization ($293.70 B vs $1.58 B).
Full pages: ANAPTYSBIO, INC and Novartis AG, or browse the full rankings.